Cyclo3pss Corporation

OTC: CYPS · Healthcare · Medical - Diagnostics & Research

PublicHQ Salt Lake City, UT · Salt LakeReports USD

#1 of 1,394 Healthcare companies by revenue

EA Score

——

FH —DQ —GM —SS 29

v0.1 · 5/100 weight · pillars only

↑ listing tenure, workforce scale · ↓ market scale, workforce scale

Methodology →

Revenue TTM

—

Rev growth YoY (TTM)

needs 8 qtrs

Net income (FY)

—

Employees

Market cap

$4.1k

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

No filed financials — private or non-XBRL filer.

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

Cyclo3pss Corporation has no structured financials on file — private or non-XBRL filer.

Peers · Healthcare

Xeno Transplants Corporation——Nemaura Medical Inc.——Tengion, Inc.——AXM Pharma, Inc.——

Neighbors

Salt Lake →

Extra Space Storage Inc.$129.5M66B Zions Bancorporation, National Association$529.0M57C HealthEquity, Inc.$1.3B82B+Merit Medical Systems, Inc.$1.5B83B+Rest Ez Inc.$0——PROG Holdings, Inc.$2.4B72B

Key facts

CEOWilliam R. Stoddard

SectorHealthcare

IndustryMedical - Diagnostics & Research

HeadquartersSalt Lake City, UT

ExchangeOTC: CYPS

Employees4

IPO date2010-07-28

Latest filings

No filings loaded — no CIK (non-SEC filer).

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.